A multicenter pilot study of nivolumab with drug-eluting bead transarterial chemoembolization in patients with liver-limited hepatocellular carcinoma.

Harding JJ, Fitzpatrick OM, Chou JF, Yarmohammadi H, Reiss KA, Do RK, Wong P, Khalil DN, El Dika I, Ferrer C, Heffernan O, Yaqubie A, Giardina JD, D'Angelica M, Jarnagin WR, Nadolski G, Covey A, Erinjeri JP, Brown K, Soulen MC, Tan B, Capanu M, Abou-Alfa GK

Open source

DOI
10.1016/j.esmogo.2026.100402
Published
2026 Sep
Container
ESMO gastrointestinal oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.esmogo.2026.100402,
  title = {A multicenter pilot study of nivolumab with drug-eluting bead transarterial chemoembolization in patients with liver-limited hepatocellular carcinoma.},
  author = {Harding JJ and Fitzpatrick OM and Chou JF and Yarmohammadi H and Reiss KA and Do RK and Wong P and Khalil DN and El Dika I and Ferrer C and Heffernan O and Yaqubie A and Giardina JD and D'Angelica M and Jarnagin WR and Nadolski G and Covey A and Erinjeri JP and Brown K and Soulen MC and Tan B and Capanu M and Abou-Alfa GK},
  year = {2026},
  journal = {ESMO gastrointestinal oncology},
  doi = {10.1016/j.esmogo.2026.100402},
  url = {https://doi.org/10.1016/j.esmogo.2026.100402}
}

RIS

TY  - JOUR
TI  - A multicenter pilot study of nivolumab with drug-eluting bead transarterial chemoembolization in patients with liver-limited hepatocellular carcinoma.
AU  - Harding JJ
AU  - Fitzpatrick OM
AU  - Chou JF
AU  - Yarmohammadi H
AU  - Reiss KA
AU  - Do RK
AU  - Wong P
AU  - Khalil DN
AU  - El Dika I
AU  - Ferrer C
AU  - Heffernan O
AU  - Yaqubie A
AU  - Giardina JD
AU  - D'Angelica M
AU  - Jarnagin WR
AU  - Nadolski G
AU  - Covey A
AU  - Erinjeri JP
AU  - Brown K
AU  - Soulen MC
AU  - Tan B
AU  - Capanu M
AU  - Abou-Alfa GK
PY  - 2026
JO  - ESMO gastrointestinal oncology
DO  - 10.1016/j.esmogo.2026.100402
UR  - https://doi.org/10.1016/j.esmogo.2026.100402
ER  - 

APA

JJ, H., OM, F., JF, C., H, Y., KA, R., RK, D., P, W., DN, K., I, E. D., C, F., O, H., A, Y., JD, G., M, D., WR, J., G, N., A, C., JP, E., K, B., MC, S., B, T., M, C., & GK, A. (2026). A multicenter pilot study of nivolumab with drug-eluting bead transarterial chemoembolization in patients with liver-limited hepatocellular carcinoma.. ESMO gastrointestinal oncology. https://doi.org/10.1016/j.esmogo.2026.100402

Source records